After Her Insurance Changed, Yvonne Castillo Was Paying $380 a Month for Prescriptions She Could Not Skip

Have you ever looked at your bank balance, felt genuinely relieved, and then opened a pharmacy receipt that erased every bit of that relief? That…

After Her Insurance Changed, Yvonne Castillo Was Paying $380 a Month for Prescriptions She Could Not Skip
After Her Insurance Changed, Yvonne Castillo Was Paying $380 a Month for Prescriptions She Could Not Skip

Have you ever looked at your bank balance, felt genuinely relieved, and then opened a pharmacy receipt that erased every bit of that relief? That specific, sinking feeling is what brought Yvonne Castillo to my attention — and ultimately, to this story.

A financial counselor in Fresno, California reached out to me in late February 2026, saying she had a client whose situation was worth telling. “She earns real money, she works hard, and she’s still being crushed,” the counselor said. “Nobody writes about people like her.” I called Yvonne the next day.

The Life She Built — and the Costs That Came With It

When I sat down with Yvonne Castillo at a coffee shop near her apartment in Fresno’s Tower District, she arrived early, laptop bag over one shoulder, already answering emails on her phone. She is 31, a widowed freelance graphic designer who lost her husband, Marco, to a sudden cardiac event in 2023. She has two adult children from a young marriage who live out of state, and she has built a self-sufficient life that, from the outside, looks entirely together.

Her freelance business brings in approximately $85,000 a year — a number she reached through discipline and years of grinding through agency work before striking out on her own in early 2024. She holds a master’s degree in design communications from a private university, a credential that cost her $47,200 in student loans and that she finished paying toward at $418 a month on a standard repayment plan.

$85,000
Yvonne’s annual freelance income

$380
Monthly out-of-pocket prescription cost

$47,200
Graduate school loan balance at peak

Those numbers, stacked together, tell a story that her income alone does not. After self-employment taxes — which she pays quarterly, roughly $19,000 a year — her effective take-home sits closer to $66,000. Subtract the loan payment, standard living costs in a mid-size California city, and the $380 a month that hit her in September 2024 when her prescription costs changed, and the margin disappears faster than she can earn it back.

The Prescription Bill That Changed Everything

The drug in question is a daily medication Yvonne takes for a thyroid condition diagnosed in her mid-twenties. While she worked at her former design agency and carried employer-sponsored group coverage, her monthly cost for the medication was $15 — a copay she barely noticed.

When she went fully freelance in January 2024, she enrolled in a marketplace plan through Covered California. The plan she could afford — a Silver-tier policy at $312 a month — did not place her medication on a favorable formulary tier. By September 2024, after a plan adjustment she hadn’t fully tracked, the drug shifted to Tier 3 status. Her monthly cost became $380.

“I remember standing at the pharmacy counter thinking there had to be a mistake. I’d taken this medication for years. I handed the pharmacist my card and she said, ‘It’s three-eighty this month.’ I paid it because what else do you do? But I drove home in a fog.”
— Yvonne Castillo, freelance graphic designer, Fresno CA

She paid it every month from September through December 2024 — $1,520 total in those four months alone. She didn’t tell anyone. Not her children, not her close friends, not the financial counselor she had begun working with for unrelated estate planning after Marco’s death. She described to me the specific mental calculus she used to justify the silence: she was earning well, she would figure it out, she didn’t want to look like she was struggling when, by most measures, she wasn’t.

“I think I inherited this idea that if you make decent money, you’re not allowed to have a money problem,” she told me, leaning forward with both hands wrapped around her coffee cup. “But the math doesn’t care about your pride.”

⚠ IMPORTANT
Marketplace plan formularies can change annually during and after open enrollment. A drug that was Tier 1 or Tier 2 in one plan year may shift to a higher cost tier the following year without direct notification to the enrollee. According to Healthcare.gov’s formulary guidance, consumers should review the drug formulary each year before re-enrolling.

What the Student Loan Situation Added

The prescription bill was the loudest problem, but it wasn’t the only one. Yvonne’s $47,200 in federal graduate student loans had been accumulating since 2019. She had been on a standard 10-year repayment plan, paying $418 a month since her six-month grace period ended in early 2020.

By the time we spoke in February 2026, she had paid down the balance to approximately $31,400. But she had never explored income-driven repayment options, partly because her income had been inconsistent during the pandemic years and partly because she assumed — incorrectly — that IDR plans were only for borrowers in financial crisis.

Repayment Type Monthly Payment Based On
Standard 10-Year $418 Fixed loan balance
SAVE Plan (IDR) Approx. $210–$240 Discretionary income
IBR Plan Approx. $270–$310 10–15% of discretionary income

Her financial counselor eventually walked her through the federal income-driven repayment options available through Federal Student Aid’s repayment plans. For a borrower at Yvonne’s income level and loan balance, the SAVE plan — Saving on a Valuable Education — would have reduced her monthly payment to somewhere between $210 and $240, depending on her adjusted gross income for that filing year. The difference of roughly $180 a month felt abstract until she thought about it as two prescriptions.

“Nobody told me about income-driven repayment when I signed my loans. I thought it was a hardship program. I didn’t think someone like me would qualify or that it was even meant for people like me. That assumption cost me years of overpaying.”
— Yvonne Castillo

Finding the Seams in the System

The turning point, as Yvonne described it to me, came in January 2025 — about four months after the pharmacy sticker shock began. She finally told her financial counselor about the prescription costs during a routine check-in call. The counselor directed her to two resources she had not known existed.

The first was the pharmaceutical manufacturer’s patient assistance program for her medication. Many major drug manufacturers maintain these programs for patients who meet income thresholds or face high out-of-pocket costs even with insurance. Yvonne’s income was above the typical low-income threshold but the program had a separate tier for patients experiencing a coverage gap — defined as paying more than a set percentage of household income on a single chronic-care medication.

Yvonne’s Path From Discovery to Relief
1
September 2024 — Prescription tier changes; monthly cost jumps from $15 to $380.

2
September–December 2024 — Pays full cost for four months totaling $1,520 without seeking help.

3
January 2025 — Discloses situation to financial counselor; learns about manufacturer assistance programs.

4
February 2025 — Approved for copay assistance; monthly prescription cost drops to $45.

5
March 2025 — Applies for SAVE income-driven repayment; monthly loan payment projected to drop by approximately $180.

The application process, she told me, took about three weeks and required documentation of her insurance plan and recent tax return. By February 2025, she was approved. Her monthly prescription cost dropped to $45 — still more than the $15 she had paid under group coverage, but $335 less than what she had been paying for four months straight.

The second resource was a referral to NeedyMeds, a nonprofit database of patient assistance programs, state pharmaceutical assistance programs, and disease-specific resources. Yvonne used it to cross-check whether she was leaving any other assistance on the table — she wasn’t, but she described the act of knowing that as its own form of relief.

KEY TAKEAWAY
Yvonne paid $1,520 in avoidable out-of-pocket prescription costs over four months because she assumed her income disqualified her from assistance programs. Manufacturer copay assistance programs are not exclusively for low-income patients — coverage gap eligibility exists for insured patients paying above a certain cost threshold for chronic medications.

What Relief Actually Looked Like — and What It Did Not Fix

By the time we met in February 2026, Yvonne was a year into a more stable financial picture. The prescription copay assistance had held. She had filed her application for SAVE plan repayment and was waiting on final processing confirmation — a backlog issue that, as of early 2026, was affecting many federal borrowers following administrative transitions at the Department of Education.

She was realistic about what had changed and what hadn’t. Her graduate debt was still real. Her self-employment tax burden was still real. She still operated without the safety net of an employer’s HR department to catch formulary changes or notify her of open enrollment options.

“I feel less like I’m bleeding money. But I won’t pretend that everything is solved. I still check my insurance plan documents more carefully than I ever used to. That anxiety doesn’t go away just because you found one answer.”
— Yvonne Castillo, February 2026

There was also the emotional cost of the four months she had spent quietly absorbing the $380 charges. She mentioned Marco during that part of our conversation — not dramatically, but plainly. She said that before he died, she had always hidden financial stress from him because she needed to be the capable one. “I kept doing it even after he was gone,” she said. “I was hiding it from a person who wasn’t there anymore. That was the part that really got to me.”

That sentence sat with me after I left the coffee shop. The financial system failed Yvonne in a measurable way — a formulary change, an information gap, an assumption that assistance programs weren’t for people with her income. But the human cost of those months was something no assistance program was designed to address.

Yvonne is not done navigating. Her Covered California enrollment window comes back around every fall, and she told me she has already calendared three hours in October to review her plan’s formulary before auto-renewing. She plans to work with her financial counselor on her 2025 tax filing to ensure her AGI is accurately calculated for any IDR recertification. Small things. Deliberate things. The kind of preparation that nobody talks about until it costs you $1,520 to learn it.

Her story is not a triumph arc with a clean ending. It is the story of an intelligent, capable woman who fell through a gap that the system does not advertise and that income alone cannot protect you from. The gap is real. And according to Yvonne Castillo, the most dangerous thing about it is that from the outside, you cannot see it at all.

Related: He Paid $374 a Month for Health Insurance on $34,000 a Year — Then One Phone Call Changed Everything

Related: Your IRS Refund Tracker Went Blank After Filing — Here’s What That Actually Means in 2026

Frequently Asked Questions

Can I get help paying for prescriptions if I have insurance but my drug is on a high-cost tier?

Yes. Many pharmaceutical manufacturers offer copay assistance or patient assistance programs for insured patients who face high out-of-pocket costs due to formulary tier placement. Yvonne Castillo’s monthly cost dropped from $380 to $45 after qualifying for one of these programs. Eligibility thresholds vary by manufacturer and drug.
What is the SAVE repayment plan for federal student loans?

The SAVE (Saving on a Valuable Education) plan is an income-driven repayment plan for federal student loans administered by the U.S. Department of Education. Payments are based on a borrower’s discretionary income and can be significantly lower than the standard 10-year repayment amount. For Yvonne Castillo’s situation, projected monthly payments dropped by approximately $180 compared to her standard plan.
How do I find out if my prescription drug tier changed on my marketplace plan?

According to Healthcare.gov, insurers can change drug formularies annually. Enrollees should review the plan’s drug formulary document each fall before the open enrollment deadline — typically November 1 through January 15 for Covered California — rather than relying on auto-renewal without review.
Is income-driven repayment only for borrowers who are struggling financially?

No. Income-driven repayment plans, including IBR and SAVE, are available to eligible federal student loan borrowers at a range of income levels. Payments are calculated as a percentage of discretionary income, typically between 5% and 15% depending on the plan. Yvonne Castillo’s situation illustrates that borrowers with upper-middle incomes may still see meaningful payment reductions under IDR plans.
Where can I look up prescription assistance programs outside of my insurance?

NeedyMeds (needymeds.org) is a nonprofit database that aggregates patient assistance programs, state pharmaceutical assistance programs, and disease-specific resources. It is free to use and covers both brand-name and generic medications.

467 articles

Vivienne Marlowe Reyes

Senior Tax & Stimulus Writer covering stimulus payments, tax credits, and IRS policy. M.S. Tax Policy Georgetown. Former U.S. Treasury analyst. Enrolled Agent.

Leave a Reply

Your email address will not be published. Required fields are marked *